Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: That other place...

That other place...

posted on Jun 17, 2008 07:13AM

It is interesting to see the range given to share repurchases when a simple visit to the SEC stipulates:

Under the amended volume condition, to qualify for the safe harbor, an issuer's total volume of Rule 10b-18 purchases effected on any single day must not exceed 25% of the ADTV in its security, which includes any block-size purchases by or on behalf of the issuer for that day. Issuers, however, can include their block-size purchases when calculating its security's four-week ADTV.

http://www.sec.gov/rules/final/33-83...



Revenue projections assuming that 2.8 million shares equates to 10% of the current quarter's revenue might also be problematic:



The stock buyback plan adopted by the Board of Directors calls for management to use not less than 10 percent of future licensing revenue distributions received by the Company to purchase shares of our stock on the open market in a manner consistent with applicable securities laws and regulations

April 24 2006





It is indeed wonderful that this place exists where precision and factual exactness are not a prerequisite (smiley)







Be well

Share
New Message
Please login to post a reply